OBR Daily Commentary

forumImage

New Study Finds COVID-19 Substantially Reduced Cancer Screenings, Diagnosis, and Treatments in 2020

(COA) Oct 21, 2020 - A new study published online today ahead of publication in the November issue of the journal JCO Clinical Cancer Informatics shows a considerable drop in cancer screening, diagnosis, and treatment for American seniors and Medicare beneficiaries this year. Oncologists who were part of the study’s research team say they are already starting to see the traumatic results, as cancers are caught at later stages requiring more complex treatments, resulting in higher morbidity, or worse, death.

Read Article arrow

Ted Okon (Posted: October 21, 2020)

quotesThis is a very important but scary study we conducted. Cancer screenings are still down and we have not seen the full impact of that. Yet, now we are in a COVID-19 3rd wave that will cause a further delay in screenings. We will see an adverse impact on patient outcomes and even mortality.quotes

Add Comment 1 Comment
forumImage

PBM Middlemen Continue to Dodge Responsibility for Patient Suffering and Rising Drug Prices

(COA) Apr 9, 2019 - COA applauds the senate finance committee for PBM hearing as part of national efforts to shed light on PBM abuses and lower drug prices. More investigation and oversight needed to examine adverse impact of PBM abuses on patient care.

Read Article arrow

Ted Okon (Posted: April 11, 2019)

quotesPBMs are getting more brazen in how they delay and deny cancer patients their oral drugs. Anyone in practice knows that. The Senate Finance hearing was a necessary first step but a lot more needs to be done — especially focusing on how PBMs are adversely impacting patient care.quotes

Add Comment 1 Comment
forumImage

Fact Checking the NYT Fact Check on the Trump Proposal

(MSK Drug Pricing Lab) Dec 17, 2018 - The Drug Pricing Lab takes issue with The New York Times ‘Fact Check’ on the recent Trump Administration proposal to pilot alternative reimbursement for Part B drugs.

Read Article arrow

Ted Okon (Posted: December 18, 2018)

quotesAs I informed Dr. Bach, at least one of his "fact check" statements are not factual. "...McKesson, which owns Texas Oncology (part of US Oncology)" is not correct because the physicians of Texas Oncology own Texas Oncology. It calls into question what other "fact checks" by Dr. Bach are incorrect.quotes

Add Comment 1 Comment

Meet the Editorial Board

Prostate Cancer
member photo
Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical O...

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Associate Clinical Professor, Medical Oncology Executi...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Woo...

Radiation Oncology
member photo
Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics Professo...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Steven Spielberg Family Chair in Hematology Oncology P...

member photo
Stephen M. Schleicher, M.D., MBA

Community Oncology, Medical Oncologist, OneOncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...